Skip to main content
Premium Trial:

Request an Annual Quote

Nexus Biosystems Acquires Aurora Biotechnologies

NEW YORK (GenomeWeb News) – Nexus Biosystems has acquired Aurora Biotechnologies for an undisclosed sum, Poway, Calif.-based Nexus said in a statement today.

Aurora makes high-performance microplates for use in sample storage, high-throughput screening, and cellular imaging. Nexus said that Aurora's technologies will complement its automated sample management systems, including its new -80degC BioStore line of sample management systems.

"As we head into 2010 with the Aurora technologies, we are very excited about the opportunity to expand our product reach beyond automated sample management into high throughput biochemical, cell-based and genomic screening applications," John Lillig, president and CEO of Nexus, said in a statement.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.